Ginkgo Bioworks Hldgs Inc (DNA)

Ahead of what could be significant uncertainties in the market, investors may be better served with cutting-edge biotech stocks. Fundamentally, the reasoning centers on relative…

7 Healthcare Stocks That Are Poised to Become the Next Unicorns

By Chandler Capital, InvestorPlace Contributor Nov 9, 2023

Discover healthcare stocks with remarkable potential for growth and "unicorn" status in the ever-evolving world of healthcare investments.

3 Biotech Stocks Ready to Break Out in 2024

By John Blankenhorn, InvestorPlace Contributor Oct 7, 2023

Still, many biotech stocks to buy are positioned well for the coming quarter and new year. These show amazing drug portfolios, promising growth potential, and world-class technology.

3 Promising Cathie Wood Stocks That Will Make Early Investors Rich

By Josh Enomoto, InvestorPlace Contributor Oct 4, 2023

Although the innovation space is getting squirrelly, these Cathie Wood stocks to make you rich provide compelling narratives.

DNA Stock Alert: Ginkgo Bioworks Announces Major Partnership With Pfizer

By Dana Blankenhorn, InvestorPlace Contributor Sep 27, 2023

The deal keeps Ginkgo alive, but its business model of becoming the "Apple Store of Biotech" remains unproven. DNA stock jumped overnight.

Cathie Wood’s Stock Shuffle: 4 Names She’s Loving, 3 She’s Leaving

By Rich Duprey, InvestorPlace Contributor Sep 27, 2023

Investors tend to closely watch which Cathie Wood stocks are bought and sold as she has history of generating big returns in her ETFs.

Immunomics Stocks: 3 Ways to Play This Massive AI-Biotech Megatrend

By John Blankenhorn, InvestorPlace Contributor Sep 22, 2023

Ginkgo Bioworks, Recursion Pharmaceutical, and Eli Lilly are cashing in on the AI-Biotech trend of tomorrow using the big data of today.

The 7 Most Undervalued Cathie Wood Stocks to Buy in September 2023

By Muslim Farooque, InvestorPlace Contributor Sep 15, 2023

Elevate your portfolio with these Cathie Wood's undervalued stocks brimming with robust long-term growth potential

DNA Stock Alert: Did Ginkgo Bioworks Just Become the Next Big AI Stock?

By Chris MacDonald, InvestorPlace Contributor Aug 29, 2023

A key announcement is driving shares of DNA stock more than 20% higher today. Ginkgo Bioworks is making waves in the AI world.

The GMO Frontier: 3 Synthetic Biology Stocks for Your Must-Buy List

By John Blankenhorn, InvestorPlace Contributor Aug 25, 2023

The industries of the future are already available for investing today. Don't get left behind as synthetic biology stocks build the future.

3 Growth Stocks Cathie Wood Is Betting On Now: August 2023

By Yiannis Zourmpanos, InvestorPlace Contributor Aug 4, 2023

Are you looking to invest in the long-term stocks? Here are three growth stocks Cathie Wood is betting on now.

7 Healthcare Stocks to Ditch Before They Make Your Portfolio Sick

By Louis Navellier and the InvestorPlace Research Staff Jul 31, 2023

For investors who choose wisely, profits in healthcare stocks can be spectacular. But the losses can also be dramatic if you choose poorly.

DNA Stock Alert: The $18 Milion Reason Ginkgo Bioworks Is Up Today

By William White, InvestorPlace Writer Jul 19, 2023

Ginkgo Bioworks (DNA) stock is rising higher on Wednesday after the company won a four-year, $18 million contract from DARPA.

Why These 3 Stocks Are the Worst Ways to Play Biotech Right Now

By Ian Bezek, InvestorPlace Contributor Jul 13, 2023

These three dangerous biotech stocks are not investable even if you're bullish on the sector overall.

DNA Stock Alert: Ginkgo Bioworks Moves Forward With Novo Nordisk Partnership

By William White, InvestorPlace Writer Jul 11, 2023

Ginkgo Bioworks (DNA) stock is on the move Tuesday after the company announced a continued partnership with Novo Nordisk.

Hero or Zero? 3 High-Risk Biotech Stocks to Make You Rich … or Broke.

By John Blankenhorn, InvestorPlace Contributor May 22, 2023

These biotech companies are swinging for the fences. They may hit homers, they may strike out. But you'll definitely want to watch them.

DNA Stock Earnings: Ginkgo Bioworks Misses EPS, Beats Revenue Estimates

By Sarah Smith, Editor-in-Chief, InvestorPlace.com May 10, 2023

DNA stock earnings show Ginkgo Bioworks missing analyst estimates for its loss per share but beating revenue estimates.

Ginkgo Bioworks Hldgs Inc (DNA)

7 Stocks Cathie Wood Is Still Loading Up On in Q1

3 Healthcare Stocks at 52-Week Lows: Buy or Bye?

AI Meets Biotech: 3 Top Stocks Transforming Medical Science

7 Small-Cap Stocks to Buy BEFORE the Year-End Rally

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Ginkgo Bioworks Hldgs Inc (DNA)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

DNA Stock Predictions, Articles, and Ginkgo Bioworks Hldgs Inc News

Subscriber Sign in